Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. - Wikidata - awgldk - TriplyDB

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

http://www.wikidata.org/entity/Q38592775

about

Microbiota and Neurological Disorders: A Gut Feeling.Overproduction of α-Lipoic Acid by Gene Manipulated Escherichia coli A Clinical Trial about a Food Supplement Containing α-Lipoic Acid on Oxidative Stress Markers in Type 2 Diabetic Patients Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.Encapsulation of the Antioxidant R-(+)-α-Lipoic Acid in Permethylated α- and β-Cyclodextrins: Thermal and X-ray Structural Characterization of the 1:1 Inclusion Complexes.Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.Epigenetic Treatment of Persistent Viral Infections.Physiology and role of irisin in glucose homeostasis.Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Chronic treatment of (R)-α-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats.In Vivo Roles of Fatty Acid Biosynthesis Enzymes in Biosynthesis of Biotin and α-Lipoic Acid in Corynebacterium glutamicum.Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.

P2860

Q24570085-E950D0BA-5ADB-443A-AE7C-DF77B44F1647 Q28469464-C0B2838D-C0FD-463A-9ABC-68C037D9567B Q37465394-14953722-5665-4736-8836-81E529B52621 Q38742951-39BB18E7-E2B8-42F3-9682-EBCFDBC03D86 Q38763354-86DB7E0E-C06E-4CF9-90EA-86D29B3114AA Q38768016-DBDE512D-A27F-4381-B780-851C42A2357C Q38985869-E7DC9677-AEE9-4B69-AFF8-95486761B67E Q39140445-1D4586C6-F313-4F6B-ACFB-52023283E64C Q39400621-4B3193C3-D978-48DD-9EA3-C106C3D00DF7 Q41853406-0CAE6FF8-DC2B-4579-A9F8-99B6A13A1A19 Q47868491-600F4313-2658-4884-B6B9-872EFB2AA41E Q47988632-1EDC5F1B-0B01-4D39-9F45-95060FAFDE0C Q52887626-AFF2D73F-DCA8-412A-BEE6-F5FB3C882E74

P2860

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

http://www.wikidata.org/entity/Q38592775

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

@en

type

label

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

@en

prefLabel

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

@en

P1433

Q38592775-89D3EEBA-B443-46BC-A29A-4FBB1D87BAB6

P1476

Q38592775-AB60A588-09E9-49EE-89E7-A2F7C63C62BD

P2093

Q38592775-B224FBCF-C259-4D86-8850-EF510027F115

P2860

Q38592775-000AF238-76AB-4D4D-873E-619E2D08FF3B

Q38592775-111219D6-EB07-4395-87C8-4D28749307F9

Q38592775-11DC5A8F-A00C-482E-9FE9-704CBA644980

Q38592775-1CCEAFD7-9A31-4F59-8AAE-EED796C6B510

Q38592775-29F4741D-C084-4B06-9C35-FA612874F683

Q38592775-2C340BCB-81F8-400E-95B3-6B9F48AD58FB

Q38592775-37CDC579-EA79-4BC2-8E52-C5981952BD94

Q38592775-3AC33B90-AFFA-4ECA-B74A-846EB63BF0C9

Q38592775-3CDDBE05-806D-4A82-81A9-112410C14CE6

Q38592775-3DEA6F57-6007-4995-8045-A2DC52A4FF7D

P304

Q38592775-3637D6EF-41AF-46CF-A611-4BD8E83FF1CD

P31

Q38592775-7324926B-10F1-4925-B73E-1BACA20322E1

P356

Q38592775-C628CA72-108D-4DB7-B369-FBA3BE13D031

P433

Q38592775-5EE9BCC6-42D6-46E8-9F24-35640A8350DB

P478

Q38592775-FBBD78C4-14B3-46B5-B5B9-5322345EA919

P50

Q38592775-035C5E89-7771-4648-95F8-58D962ED6536

Q38592775-35F7DF92-F4F2-46E7-9709-A7FC07871432

Q38592775-E1107109-D623-4D28-9B67-6F68EA43BE36

P577

Q38592775-D550AD06-6C70-4C82-9346-2CC8148E9B92

P698

Q38592775-3BC432B0-C5E2-4B67-AAF3-F3E71D1245A2

P356

P1433

Canadian Journal of Physiology and Pharmacology

P1476

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes

@en

P2093

Adriana Muresan

http://www.w3.org/2001/XMLSchema#string

P2860

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Glutathione synthesis

Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage

alpha-Lipoic acid as a biological antioxidant.

Retinopathy in diabetes

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Reversible inhibition of alpha-ketoglutarate dehydrogenase by hydrogen peroxide: glutathionylation and protection of lipoic acid.

Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity.

α-Ketoglutarate dehydrogenase: a mitochondrial redox sensor

Molecular aspects of lipoic acid in the prevention of diabetes complications.

P304

1021-1027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/CJPP-2014-0353

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Vergely

P577

2015-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26406389

http://www.w3.org/2001/XMLSchema#string